Resumen
Diferenciales
Común
- Fibroadenoma
- Mama fibroquística
- Esteatonecrosis
- Papiloma intraductal
- Absceso mamario
- Cáncer de mama invasivo
- Carcinoma ductal in situ (CDIS)
Infrecuente
- Tumor filoides
- Adenoma
- Hiperplasia ductal atípica (HDA) e hiperplasia lobular atípica (HLA)
- Cicatriz radial
- Carcinoma lobular in situ (CLIS)
Colaboradores
Autores
Marios-Konstantinos Tasoulis, MD, PhD
Consultant Breast Surgeon
Breast Surgery Unit
The Royal Marsden Hospital NHS Foundation Trust
London
UK
Divulgaciones
M-KT declares that he has no competing interests.
Samantha Muktar, MBBS, FRCS (Eng), MSc, BMedSci
Consultant Breast Surgeon
Breast Surgery Unit
London North West University Healthcare
London
UK
Divulgaciones
SM declares that she has no competing interests.
Agradecimientos
Dr Marios-Konstantinos Tasoulis would like to gratefully acknowledge Professor Anees Chagpar and Dr Matthew Bower, previous contributors to this topic.
Divulgaciones
AC and MB declare that they have no competing interests.
Revisores por pares
William Dooley, MD, FACS
Director of Surgical Oncology
Department of Surgery
University of Oklahoma
G. Rainey Williams Chair in Surgical Breast Oncology
OU Breast Institute
Oklahoma City
OK
Divulgaciones
WD declares that he has no competing interests.
Jesus Solier Insuasty Enriquez, MD
Oncology Unit
Hospital Universitario Ramon Gonzalez Valencia
Bucaramanga
Colombia
Divulgaciones
JE declares that he has no competing interests.
Justin Stebbing, MA, MRCP, MRCPath, PhD
Consultant Medical Oncologist/Senior Lecturer
Department of Medical Oncology
Imperial College/Imperial Healthcare NHS Trust
Charing Cross Hospital
London
UK
Divulgaciones
JS declares that he has no competing interests.
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad